eCancerMedicalScience
Scope & Guideline
Connecting minds to conquer cancer.
Introduction
Aims and Scopes
- Cancer Epidemiology and Public Health:
The journal covers studies that analyze cancer incidence, prevalence, and mortality rates, particularly in underrepresented populations, thereby contributing to a more comprehensive understanding of cancer's impact globally. - Innovative Treatment Modalities:
Research articles focus on novel therapies, including immunotherapy, targeted treatments, and combination therapies, highlighting their effectiveness in diverse patient populations and addressing disparities in access to care. - Healthcare Systems and Policy:
The journal explores the intersection of cancer care and health policy, examining how healthcare systems can be optimized to improve access, quality, and equity in cancer treatment, especially in resource-limited settings. - Patient-Centered Care and Survivorship:
The scope includes studies on quality of life, psychosocial aspects of cancer care, and survivorship issues, emphasizing the importance of holistic approaches to cancer treatment. - Educational and Training Initiatives:
The journal promotes articles that assess and enhance oncology education and training for healthcare professionals, particularly in low-resource environments, to improve cancer management and outcomes.
Trending and Emerging
- Telemedicine and Digital Health Solutions:
The rise of telemedicine, especially during the COVID-19 pandemic, has led to increased research on its implementation in oncology, highlighting its potential to improve access to care and patient outcomes. - Health Disparities and Access to Care:
There is a growing focus on understanding and addressing disparities in cancer care, particularly in low- and middle-income countries, emphasizing the need for equitable healthcare solutions. - Immunotherapy and Personalized Medicine:
An increasing number of studies are dedicated to exploring immunotherapy and personalized treatment plans, reflecting a shift towards more effective and individualized cancer treatments. - Survivorship and Quality of Life Research:
Research on survivorship issues, including long-term effects of cancer treatment and quality of life assessments, is gaining traction, emphasizing the importance of holistic care for cancer survivors. - Interdisciplinary Approaches in Cancer Care:
Emerging themes include the integration of different specialties in cancer treatment, such as combining surgical, medical, and supportive care, to enhance patient outcomes and streamline treatment pathways.
Declining or Waning
- Traditional Chemotherapy Approaches:
There has been a noticeable decrease in publications focusing solely on conventional chemotherapy regimens, as research increasingly shifts towards personalized medicine and targeted therapies that offer more effective treatment options. - General Cancer Awareness Campaigns:
While still relevant, the frequency of articles solely dedicated to general cancer awareness initiatives has decreased, possibly due to a growing emphasis on specific interventions and evidence-based strategies tailored to particular populations. - Palliative Care Focused Studies:
Although palliative care remains crucial, there has been a waning interest in studies that do not integrate palliative approaches with oncological treatments, suggesting a trend towards more comprehensive care models. - Single-Institution Studies:
Research focusing exclusively on single-institution experiences is becoming less common, as collaborative and multi-centre studies gain traction, reflecting a desire for broader applicability and generalizability of findings. - Basic Science and Laboratory Research:
There appears to be a decline in studies rooted in basic science related to oncology, as clinical applications and translational research take precedence in addressing urgent clinical needs.
Similar Journals
Current Oncology
Empowering Research, Enriching LivesCurrent Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.
Cancer Reports
Advancing cancer research for a healthier tomorrow.Cancer Reports, published by WILEY, is an esteemed open-access journal dedicated to the field of oncology and cancer research. With a focus on disseminating impactful research findings since its transition to fully open access in 2021, Cancer Reports aims to facilitate knowledge sharing among researchers, clinicians, and healthcare professionals globally. The journal is positioned within the Q3 quartile for both Cancer Research and Oncology categories as of 2023, reflecting its commitment to quality and relevance in a competitive publishing landscape. With an ISSN of N/A and an E-ISSN of 2573-8348, the journal showcases studies across diverse aspects of cancer biology, treatment modalities, and patient care strategies. Located in the United Kingdom at 111 River St, Hoboken 07030-5774, NJ, Cancer Reports strives to contribute to the advancement of cancer research and improve health outcomes for patients worldwide, making it a pivotal platform for scholars and practitioners in the oncology community.
ONCOLOGY-NEW YORK
Fostering Collaboration in the Oncology Community.ONCOLOGY-NEW YORK is a prominent journal dedicated to the field of oncology, published by UBM MEDICA. Since its inception in 1987, the journal has served as a pivotal platform for disseminating groundbreaking research and advancements in cancer treatment, research, and education. With an ISSN of 0890-9091 and an E-ISSN of 2767-7389, it stands as an accessible resource for professionals, researchers, and students alike. The journal currently holds impressive rankings, categorized within Q3 in Oncology and Q4 in Cancer Research for 2023, reflecting its commitment to high-quality research output and contributions to the field. Despite its challenges in Scopus rankings, positioned at #283/404 in Medicine: Oncology and #188/230 in Biochemistry, Genetics, and Molecular Biology: Cancer Research, ONCOLOGY-NEW YORK continues to primarily focus on innovative cancer therapies and emerging clinical research. The journal's ongoing dedication to enhancing knowledge and understanding in oncology makes it a vital resource for all stakeholders invested in combating cancer.
Cancer Management and Research
Illuminating the complexities of oncology for better health.Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.
BREAST
Shaping the future of oncology with peer-reviewed excellence.BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.
World Journal of Oncology
Connecting insights to combat cancer effectively.The World Journal of Oncology, published by ELMER PRESS INC, is a vibrant platform for disseminating groundbreaking research and advancements in the field of oncology. With its ISSN 1920-4531 and E-ISSN 1920-454X, this journal is dedicated to publishing high-quality studies that enhance our understanding of cancer and its treatment. The journal is recognized for its significant contributions, evidenced by its Q2 classification in both Cancer Research and Oncology categories in 2023, and accolades such as a Scopus rank of #126/404 in Medicine _ Oncology. Catering to the needs of researchers, professionals, and students, the World Journal of Oncology offers an essential resource for the latest scientific insights and clinical practices, ensuring the global oncology community remains informed and engaged. The journal operates under a selective publication model, maintaining rigor in peer review while facilitating knowledge sharing across converged years from 2014 to 2016 and 2020 to 2024, further establishing its importance in the ongoing fight against cancer.
ONCOLOGY
Leading the charge against cancer with rigorous scholarship.ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.
ACTA ONCOLOGICA
Shaping the future of cancer treatment and research.ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.
Trends in Cancer
Leading the Charge in Cutting-Edge Cancer DiscoveriesTrends in Cancer is a leading journal published by CELL PRESS, dedicated to advancing the field of cancer research and oncology. Since its inception in 2015, the journal has rapidly gained a reputation for excellence, securing both Q1 rankings in Cancer Research and Oncology categories for 2023 and boasting impressive Scopus ranks—#13 out of 404 in Medicine Oncology and #9 out of 230 in Biochemistry, Genetics and Molecular Biology, thus placing it in the top 4% of its field. The journal aims to publish high-quality, innovative research that offers new insights into cancer biology and treatment strategies. With a commitment to scholarly rigor and a broad scope that encompasses molecular mechanisms to therapeutic approaches, Trends in Cancer serves as an essential resource for researchers, professionals, and students eager to stay informed about the latest developments in cancer science. Although it is not an open-access journal, its contributions are pivotal in shaping the future of cancer research.
Revista Colombiana de Cancerologia
Fostering Knowledge Sharing in the Fight Against CancerRevista Colombiana de Cancerologia is a premier journal dedicated to advancing the field of oncology in Colombia and beyond. Published by the Instituto Nacional de Cancerología, this journal serves as a vital platform for the dissemination of high-quality research, comprehensive reviews, and innovative methodologies pertinent to cancer research and treatment. With an ISSN of 0123-9015 and E-ISSN 2346-0199, it aims to engage a diverse audience, including researchers, healthcare professionals, and students, fostering collaboration and knowledge sharing within the oncology community. Although specific metrics such as impact factors and H-index are currently unavailable, the journal is committed to maintaining high academic standards and encouraging open access to vital oncological insights. The Revista Colombiana de Cancerologia is positioned as an essential resource for those interested in the latest advancements in cancer care, prevention, and research methodologies, making significant contributions to the understanding and management of cancer.